Transfer of plasmid-mediated CTX-M-9 from Salmonella enterica serotype virchow to Enterobacteriaceae in human flora-associated rats treated with cefixime

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 1, 2010, Pages 164-169

  Faure, S ^a   Perrin Guyomard, A ^a   Delmas, J M ^a   Chatre, P ^a   Laurentie, M ^a  

^a Healthy Pigs Production and Experimentation Section   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; BETA LACTAMASE CTX M; CEFIXIME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GENETIC RESISTANCE; NONHUMAN; PRIORITY JOURNAL; RAT; SALMONELLA ENTERICA; SEROTYPE;

ANIMALS; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEFIXIME; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CONJUGATION, GENETIC; CULTURE MEDIA; ENTEROBACTERIACEAE; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; FECES; FEMALE; HUMANS; INTESTINES; MALE; MASS SPECTROMETRY; MICE; MICE, INBRED C3H; MICROBIAL SENSITIVITY TESTS; PLASMIDS; RATS; SALMONELLA ENTERICA;

EID: 73849092448     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00310-09     Document Type: Article

References (45)

1. Adamczyk, M., and G. Jagura-Burdzy. 2003. Spread and survival of promiscuous IncP-1 plasmids. Acta Biochim. Pol. 50:425-453.
2. Bej, A. K., J. L. DiCesare, L. Haff, and R. M. Atlas. 1991. Detection of Escherichia coli and Shigella spp. in water by using the polymerase chain reaction and gene probes for uid. Appl. Environ. Microbiol. 57:1013-1017.
3. Bej, A. K., S. C. McCarty, and R. M. Atlas. 1991. Detection of coliform bacteria and Escherichia coli by multiplex polymerase chain reaction: comparison with defined substrate and plating methods for water quality monitoring. Appl. Environ. Microbiol. 57:2429-2432.
4. Bertrand, S., F.-X. Weill, A. Cloeckaert, M. Vrints, E. Mairiaux, K. Praud, K. Dierick, C. Wildemauve, C. Godard, P. Butaye, H. Imberechts, P. A. Grimont, and J. M. Collard. 2006. Clonal emergence of extended-spectrum ß-lactamase (CTX-M-2)-producing Salmonella enterica serovar Virchow isolates with reduced susceptibilities to ciprofloxacin among poultry and humans in Belgium and France (2000 to 2003). J. Clin. Microbiol. 44:2897-2903.
5. Blake, D., K. Hillman, D. Fenlon, and J. Low. 2003. Transfer of antibiotic resistance between commensal and pathogenic members of the Enterobacteriaceae under ileal conditions. J. Appl. Microbiol. 95:428-436.
6. Bonner, J. 1997. Hooked on drugs: farm animals given antibiotics need less food to grow. New Sci. 153:24-27.
7. Bou, G., M. Cartelle, M. Tomas, D. Canle, F. Molina, R. Moure, J. Eiros, and A. Guerrero. 2002. Identification and broad dissemination of the CTX-M-14 beta-lactamase in different Escherichia coli strains in the northwest area of Spain. J. Clin. Microbiol. 40:4030-4036.
8. Bourgeois-Nicolaos, N., C. Moubareck, N. Mangeney, M.-J. Butel, and F. Doucet-Populaire. 2006. Comparative study of vanA gene transfer from Enterococcus faecium to Enterococcus faecalis and to Enterococcus faecium in the intestine of mice. FEMS Microbiol. Lett. 254:27-33.
9. Cantón, R., T. Coque, and F. Baquero. 2003. Multi-resistant Gram-negative bacilli: from epidemics to endemics. Infect. Dis. 16:315-325.
10. Cantón, R., and T. M. Coque. 2006. The CTX-M beta-lactamase pandemic. Curr. Opin. Microbiol. 9:466-475.
11. Chachaty, E., C. Bourneix, S. Renard, M. Bonnay, and A. Andremont. 1993. Shedding of Clostridium difficile, fecal beta-lactamase activity, and gastrointestinal symptoms in 51 volunteers treated with oral cefixime. Antimicrob. Agents Chemother. 37:1432-1435.
12. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing; 19th informational supplement M100-S19. Clinical and Laboratory Standards Institute, Wayne, PA.
13. Coleman, W., P. Goebel, and L. Leive. 1977. Genetic analysis of Escherichia coli O111:B4, a strain of medical and biochemical interest. J. Bacteriol. 130:656-660.
14. Coque, T. M., A. Novais, A. Carattoli, L. Poirel, J. Pitout, L. Peixe, F. Baquero, R. Canton, and P. Nordmann. 2008. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15. Emerg. Infect. Dis. 14:195-200.
15. Denton, M. 2007. Enterobacteriaceae. Int. J. Antimicrob. Agents 29(Suppl. 3):S9-S22.
16. Duval-Iflah, Y., P. Raibaud, and M. Rousseau. 1981. Antagonisms among isogenic strains of Escherichia coli in the digestive tracts of gnotobiotic mice. Infect. Immun. 34:957-969.
17. Duval-Iflah, Y., P. Raibaud, C. Tancrede, and M. Rousseau. 1980. R-plasmid transfer from Serratia liquefaciens to Escherichia coli in vitro and in vivo in the digestive tract of gnotobiotic mice associated with human fecal flora. Infect. Immun. 28:981-990.
18. Duverne, C., A. Bouten, A. Deslandes, J. Westphal, J. Trouvin, R. Farinotti, and C. Carbon. 1992. Modification of cefixime bioavailability by nifedipine in humans: involvement of the dipeptide carrier system. Antimicrob. Agents Chemother. 36:2462-2467.
19. Faure, S., A. Perrin-Guyomard, J.-M. Delmas, and M. Laurentie. 2009. Impact of therapeutic treatment with beta-lactam on transfer of the blaCTXM-9 resistance gene from Salmonella enterica serovar Virchow to Escherichia coli in gnotobiotic rats. Appl. Environ. Microbiol. 75:5523-5528.
20. Galanakis, E., M. Bitsori, S. Maraki, C. Giannakopoulou, G. Samonis, and Y. Tselentis. 2007. Invasive non-typhoidal salmonellosis in immunocompetent infants and children. Int. J. Infect. Dis. 11:36-39.
21. CTX-M-9 from Escherichia coli and Salmonella enterica strains isolated from poultry and humans. Antimicrob. Agents Chemother. 51:4177-4180.
22. Hasman, H., D. Mevius, K. Veldman, I. Olesen, and F. M. Aarestrup. 2005. Beta-lactamases among extended-spectrum beta-lactamase (ESBL)-resistant Salmonella from poultry, poultry products and human patients in The Netherlands. J. Antimicrob. Chemother. 56:115-121.
23. Hudault, S., J. Guignot, and A. Servin. 2001. Escherichia coli strains colonising the gastrointestinal tract protect germfree mice against Salmonella typhimurium infection. Gut 49:47-55.
24. Johnsen, P. J., G. S. Simonsen, O. Olsvik, T. Midtvedt, and A. Sundsfjord. 2002. Stability, persistence, and evolution of plasmid-encoded VanA glycopeptide resistance in enterococci in the absence of antibiotic selection in vitro and in gnotobiotic mice. Microb. Drug Resist. 8:161-170.
25. Lavilla, S., J. J. Gonzalez-Lopez, E. Miro, A. Dominguez, M. Llagostera, R. M. Bartolome, B. Mirelis, F. Navarro, and G. Prats. 2008. Dissemination of extended-spectrum beta-lactamase-producing bacteria: the food-borne outbreak lesson. J. Antimicrob. Chemother. 61:1244-1251.
26. Léonard, F., A. Andremont, B. Leclerq, R. Labia, and C. Tancrede. 1989. Use of beta-lactamase-producing anaerobes to prevent ceftriaxone from degrading intestinal resistance to colonization. J. Infect. Dis. 160:274-280.
27. Lester, C. H., N. Frimodt-Moller, T. L. Sorensen, D. L. Monnet, and A. M. Hammerum. 2006. In vivo transfer of the vanA resistance gene from an Enterococcus faecium isolate of animal origin to an E. faecium isolate of human origin in the intestines of human volunteers. Antimicrob. Agents Chemother. 50:596-599.
28. Mendonça, N., J. Leitao, V. Manageiro, E. Ferreira, and M. Canica. 2007. Spread of extended-spectrum beta-lactamase CTX-M-producing Escherichia coli clinical isolates in community and nosocomial environments in Portugal. Antimicrob. Agents Chemother. 51:1946-1955.
29. Meng, F., X. Chen, Y. Zeng, and D. Zhong. 2005. Sensitive liquid chromatography-tandem mass spectrometry method for the determination of cefixime in human plasma: application to a pharmacokinetic study. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 819:277-282.
30. Mesa, R. J., V. Blanc, A. R. Blanch, P. Cortes, J. J. Gonzalez, S. Lavilla, E. Miro, M. Muniesa, M. Saco, M. T. Tortola, B. Mirelis, P. Coll, M. Llagostera, G. Prats, and F. Navarro. 2006. Extended-spectrum beta-lactamaseproducing Enterobacteriaceae in different environments (humans, food, animal farms and sewage). J. Antimicrob. Chemother. 58:211-215.
31. Meunier, D., E. Jouy, C. Lazizzera, M. Kobisch, and J.-Y. Madec. 2006. CTX-M-1- and CTX-M-15-type beta-lactamases in clinical Escherichia coli isolates recovered from food-producing animals in France. J. Antimicrob. Agents 28:402-407.
32. Novais, A., R. Canton, R. Moreira, L. Peixe, F. Baquero, and T. M. Coque. 2007. Emergence and dissemination of Enterobacteriaceae isolates producing CTX-M-1-like enzymes in Spain are associated with IncFII (CTX-M-15) and broad-host-range (CTX-M-1, -3, and -32) plasmids. Antimicrob. Agents Chemother. 51:796-799.
33. Perrin-Guyomard, A., S. Cottin, D. Corpet, J. Boisseau, and J. Poul. 2001. Evaluation of residual and therapeutic doses of tetracycline in the humanflora-associated (HFA) mice model. Regul. Toxicol. Pharmacol. 34:125-136.
34. Perrin-Guyomard, A., J. Poul, D. Corpet, P. Sanders, A. Fernández, and M. Bartholomew. 2005. Impact of residual and therapeutic doses of ciprofloxacin in the human-flora-associated mice model. Regul. Toxicol. Pharmacol. 42:151-160.
35. Perrin-Guyomard, A., J. Poul, M. Laurentie, P. Sanders, A. Fernández, and M. Bartholomew. 2006. Impact of ciprofloxacin in the human-flora-associated (HFA) rat model: comparison with the HFA mouse model. Regul. Toxicol. Pharmacol. 45:66-78.
36. Prats, G., B. Mirelis, E. Miró, F. Navarro, T. Llovet, J. Johnson, N. Camps, Á. Domínguez, and L. Salleras. 2003. Cephalosporin-resistant Escherichia coli among summer camp attendees with salmonellosis. Emerg. Infect. Dis. 9:1273-1280.
37. Prescott, J. F. 2000. Antimicrobial drugs: miracle drugs or pig feed? Adv. Pork Prod. 11:37-45.
38. Rodríguez-Baño, J., L. Lopez-Cerero, M. D. Navarro, P. D. de Alba, and A. Pascual. 2008. Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. J. Antimicrob. Chemother. 62:1142-1149.
39. Sakamoto, H., T. Hirose, and Y. Mine. 1985. Pharmacokinetic of FK027 in rats and dogs. J. Antibiot. (Tokyo) 38:496-504.
40. Schjørring, S., C. Struve, and K. A. Krogfelt. 2008. Transfer of antimicrobial resistance plasmids from Klebsiella pneumoniae to Escherichia coli in the mouse intestine. J. Antimicrob. Chemother. 62:1086-1093.
41. Scientific Medical Publications of France. 2009. Dictionnaire Vidal 2009. Scientific Medical Publications of France, Inc., New York, NY.
42. Stark, C., C. Edlund, M. Hedberg, and C. Nord. 1995. Induction of beta-lactamase production in the anaerobic microflora by cefoxitin. Clin. Infect. Dis. 20(Suppl. 2):S350-S351.
43. Su, L. H., C. Chu, A. Cloeckaert, and C. H. Chiu. 2008. An epidemic of plasmids? Dissemination of extended-spectrum cephalosporinases among Salmonella and other Enterobacteriaceae. FEMS Immunol. Med. Microbiol. 52:155-168.
44. Trémolières, F., R. Azarian, F. Lebas, C. Mayaud, P. Carré, and J. Micolle. 2000. Efficacy and tolerance of two oral dosages of augmentin 1 g/125 mg twice a day versus 500 mg/125 mg thrice a day in acute exacerbations of chronic bronchitis. A multicenter comparative randomized double blind study. Med. Mal. Infect. 30:630-640.
45. Weill, F.-X., R. Lailler, K. Praud, A. Kerouanton, L. Fabre, A. Brisabois, P. A. Grimont, and A. Cloeckaert. 2004. Emergence of extended-spectrum-beta-lactamase (CTX-M-9)-producing multiresistant strains of Salmonella enterica serotype Virchow in poultry and humans in France. J. Clin. Microbiol. 42:5767-5773.